0.5798  0.032 (5.88%)		08-26 16:00
Open: 0.587 High: 0.587 Volume: 4,876		Pre. Close: 0.5476 Low: 0.56 Market Cap: 5(M)

Short term
Mid term
Targets	6-month :	0.85	1-year :	1.02
Resists	First :	0.72	Second :	0.87
Pivot price	0.56
Supports	First :	0.48	Second :	0.4
MAs	MA(5) :	0.55	MA(20) :	0.55
	MA(100) :	0.61	MA(250) :	0.86
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	27.5	D(3) :	30.1
RSI	RSI(14): 50.5
52-week	High :	2.01	Low :	0.38

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GELS ] has closed below upper band by 24.7%. Bollinger Bands are 83.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.59 - 0.59	0.59 - 0.59
Low:	0.55 - 0.56	0.56 - 0.56
Close:	0.58 - 0.58	0.58 - 0.58

Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.

Thu, 13 Aug 2026
Gelteq Limited (GELS) Advances 2.98% as Shares Defend Support at $0.56 - Bollinger Expansion - dars.gov.et

Fri, 03 Jul 2026
Gelteq Limited (GELS) Slides 12% as Selling Pressure Intensifies - Buyback Factor - dars.gov.et

Sat, 20 Jun 2026
Gelteq Limited (GELS) Slides 8.8% as Selling Pressure Intensifies Below Key Moving Averages - Debt Free Companies - dars.gov.et

Fri, 25 Apr 2025
Gelteq (GELS) Stock Price, News & Analysis - Stock Titan

Tue, 22 Apr 2025
GELS Stock Soars: Is It Time to Invest? - StocksToTrade

Fri, 18 Apr 2025
Gelteq Limited (GELS) Live Share Price, Invest From India - INDmoney

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	0 (M)
Shares Float	11 (M)
Held by Insiders	5.15e+006 (%)
Held by Institutions	47.5 (%)
Shares Short	167 (K)
Shares Short P.Month	0 (K)

EPS	-5.14e+006
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-1 %
Return on Assets (ttm)	985.2 %
Return on Equity (ttm)	-17.7 %
Qtrly Rev. Growth	471800 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	-0.6 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-3 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	33880
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.